Content about Otolaryngology

August 21, 2013

High-end supermarket chain Fairway Market has introduced a hearing loop at its flagship store's deli counter for customers with hearing loss, the chain's parent company said Wednesday.

NEW YORK — High-end supermarket chain Fairway Market has introduced a hearing loop at its flagship store's deli counter for customers with hearing loss, the chain's parent company said Wednesday.

Fairway Group Holdings, based in New York, said the loop was installed in its Broadway store in Manhattan. The loop works with a person's telecoil-equipped hearing instrument or cochlear implant, allowing the employee behind the deli to speak into a microphone and transmit the signal wirelessly to the telecoil, blocking ambient background noise and amplifying the clerk's voice.

June 14, 2012

Crown Dynamics on Wednesday launched its patented Air Sleep/Snore product line.

SCOTTSDALE, Ariz. — Crown Dynamics on Wednesday launched its patented Air Sleep/Snore product line. The products are infused with a proprietary blend of therapeutic essential oils shown to promote sleep while gently dilating nasal passages to help increase oxygen flow and decrease snoring.

February 16, 2012

Though an estimated 26.7 million Americans ages 50 years and older have hearing loss, only about 1-in-7 of them uses a hearing aid, according to a new study led by Johns Hopkins researchers that was released Monday.

BALTIMORE — Though an estimated 26.7 million Americans ages 50 years and older have hearing loss, only about 1-in-7 of them uses a hearing aid, according to a new study led by Johns Hopkins researchers that was released Monday.

Johns Hopkins experts estimate nearly 23 million have untreated hearing loss and suggest that their findings add clarity to less rigorous estimates by device manufacturers and demonstrates how widespread undertreatment of hearing loss is in the United States.

January 4, 2012

Panasonic Healthcare Group on Tuesday announced the introduction of the R1-W digital hearing instrument, a line of hearing products that appeals to a broader user base of people with mild to severe hearing loss.

SECAUCUS, N.J. — Panasonic Healthcare Group on Tuesday announced the introduction of the R1-W digital hearing instrument, a line of hearing products that appeals to a broader user base of people with mild to severe hearing loss.

November 15, 2011

Nearly one-fifth of all Americans ages 12 years and older have hearing loss so severe that it may make communication difficult, according to a new study led by Johns Hopkins researchers and published in the Nov. 14 issue of the Archives of Internal Medicine.

BALTIMORE — Nearly one-fifth of all Americans ages 12 years and older have hearing loss so severe that it may make communication difficult, according to a new study led by Johns Hopkins researchers and published in the Nov. 14 issue of the Archives of Internal Medicine. The findings, thought to be the first nationally representative estimate of hearing loss, suggest that many more people than previously thought are affected by this condition.

April 25, 2011

Anglo-Swedish drug maker AstraZeneca has made the drug vandetanib available to certain thyroid cancer patients.

WILMINGTON, Del. — Anglo-Swedish drug maker AstraZeneca has made the drug vandetanib available to certain thyroid cancer patients.

The drug maker announced Monday that the drug would be available to patients with medullary thyroid cancer that could not be removed surgically or that had spread to other parts of the body. The Food and Drug Administration approved the drug on April 6, and it is available exclusively through the pharmacy business unit of Biologics Inc., an integrated cancer management company.

March 4, 2011

KANSAS CITY, Mo. — Splintek Health Products recently launched its SleepRight Nasal Breathe Aid — a snore-relieving product entry into the nasal strip category that retails for a suggested $11.99.

According to the company, the product reduces snoring, relieves nasal congestion and is adhesive-free and reusable. Flexible flares expand the nasal passages to significantly increase airflow, while forming to the shape of the user’s nose for a custom, comfortable fit. Each SleepRight Breathe Aid lasts up to 15 days. 

February 23, 2011

Splintek Health Products recently launched its SleepRight nasal breathe aide — a snore-relieving product entry into the nasal strip category that retails for a suggested price of $11.99.

KANSAS CITY, Mo. — Splintek Health Products recently launched its SleepRight nasal breathe aid — a snore-relieving product entry into the nasal strip category that retails for a suggested price of $11.99.

According to the company, the product reduces snoring, relieves nasal congestion and is adhesive-free and reusable. Flexible flares expand the nasal passages to significantly increase airflow, while forming to the shape of the user’s nose for a custom, comfortable fit. Each breathe aid is reusable and lasts up to 15 days.

February 18, 2011

A recent Prestige Brands survey linked certain professions to a propensity for sore throats. The careers most commonly associated with sore-throat pain were singers (53%) and auctioneers (40%). Healthcare workers (47%) and teachers (37%) also were perceived to be at risk due to their potential exposure to airborne illnesses. Almost 3-out-of-4 of those sore-throat sufferers also were under the weather from a cold or flu.

January 25, 2011

Pittsburgh and Green Bay, Wis., retailers ought to have plenty of sore throat remedies in preparation for the Super Bowl — 28% of sore throat sufferers got that pain by cheering and screaming, according to a new study released Tuesday by Prestige Brands.

IRVINGTON, N.Y. — Pittsburgh and Green Bay, Wis., retailers ought to have plenty of sore throat remedies in preparation for the Super Bowl — 28% of sore throat sufferers got that pain by cheering and screaming, according to a new study released Tuesday by Prestige Brands.

September 22, 2010

The Food and Drug Administration has accepted AstraZeneca’s regulatory application for an investigational cancer drug,...

LONDON The Food and Drug Administration has accepted AstraZeneca’s regulatory application for an investigational cancer drug, the Anglo-Swedish drug maker said Thursday.

 

AstraZeneca announced the FDA’s acceptance of its application for vandetanib, a drug for treating patients with advanced medullary thyroid cancer. The agency gave the drug priority review status and expected to take action on it in January.